HE staining further confirmed a decrease in tumor infiltration depth across the treated groups, with the Vtnfl/fl S100a4‐Cre++aPD1 group showing the most profound therapeutic effect (Figure 7I; Figure S9F, Supporting Information). The gene discussed is S100A4; the disease is neoplasm.